Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy
- 1 June 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 140 (6) , 1065-1071
- https://doi.org/10.1046/j.1365-2133.1999.02905.x
Abstract
In the immunohistology of malignant melanoma the use of polyclonal antibodies against protein S100 is well established. Recently, it was shown that S100B, a subunit of the S100 protein family, is det...Keywords
This publication has 21 references indexed in Scilit:
- Clinical and prognostic relevance of serum S‐100β protein in malignant melanomaBritish Journal of Dermatology, 1998
- Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanomaBritish Journal of Dermatology, 1997
- Elevated serum levels of S100 and survival in metastatic malignant melanomaBritish Journal of Cancer, 1997
- Prognostic value of serum analyses of S-100β protein in malignant melanomaMelanoma Research, 1996
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against s-100 subunitsCancer, 1990
- The S-100 protein in cerebrospinal fluid: A simple ELISA methodJournal of the Neurological Sciences, 1989
- S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.Stroke, 1987
- An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.Journal of Clinical Pathology, 1985
- An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissuesThe American Journal of Surgical Pathology, 1982